Anaplastic large cell lymphoma (ALCL), ALK-negative, is a type of non-Hodgkin lymphoma characterized by the proliferation of large, atypical lymphoid cells. This condition primarily affects lymph nodes in the inguinal region and low lymphatic areas. Accurate coding with ICD-10 Code C84.75 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and resources.
ICD-10 Code C84.75 represents anaplastic large cell lymphoma that is anaplastic lymphoma kinase (ALK) negative, specifically affecting lymph nodes in the inguinal region and low lymphatic areas. This code is used in clinical documentation and billing when diagnosing patients with this specific type of lymphoma, ensuring accurate representation of the patient's condition for treatment and reimbursement purposes.
Anaplastic large cell lymphoma (ALCL), ALK-negative, is a rare and aggressive form of non-Hodgkin lymphoma that arises from T-cells. It is characterized by the presence of large, atypical lymphoid cells and often presents with lymphadenopathy in the inguinal region. Prompt diagnosis and treatment are crucial due to its aggressive nature and potential for systemic involvement.
ICD-10 Code C84.75 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans related to anaplastic large cell lymphoma. This code plays a vital role in both acute and chronic care settings, ensuring comprehensive documentation for effective patient management and billing.
In SOAP notes, ICD-10 Code C84.75 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of anaplastic large cell lymphoma. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
The management of anaplastic large cell lymphoma, ALK-negative, often requires urgent medical intervention due to its aggressive nature. Treatment typically involves chemotherapy and may include targeted therapies.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C84.75 is critical in medical billing, particularly in hospital, emergency room, or oncology settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 99223 | Initial hospital care, typically 70 minutes or more. |
| 85025 | Complete blood count with differential. |
| 77021 | CT scan of the abdomen and pelvis. |
Common Questions About Using ICD-10 Code C84.75 for Anaplstc lg cell lymph, ALK-neg, nodes of ing rgn & low lmb
What are the common symptoms of anaplastic large cell lymphoma?
Common symptoms include swollen lymph nodes, unexplained weight loss, fever, night sweats, and fatigue. Patients may also experience pain in affected areas.
How is anaplastic large cell lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy of affected lymph nodes to confirm the presence of atypical lymphoid cells.
What is the treatment for ALK-negative anaplastic large cell lymphoma?
Treatment usually involves chemotherapy, and in some cases, targeted therapies may be considered. Supportive care is also important to manage symptoms and side effects.
Is anaplastic large cell lymphoma contagious?
No, anaplastic large cell lymphoma is not contagious. It is a type of cancer that arises from the body's immune cells and cannot be transmitted from person to person.
Clinical Notes
SOAP notes
DAP notes
AI medical notes